Metropolitan Life Insurance Company (MetLife)’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-438	Closed	-$10.6K	–	2368
2022 Q2	$10.6K	Hold	438	–	–	﹤0.01%	2300
2022 Q1	$21.8K	Sell	438 -703	-62%	-$34.7K	﹤0.01%	2048
2021 Q4	$80.1K	Sell	1,141 -96	-8%	-$8.09K	﹤0.01%	2590
2021 Q3	$115K	Sell	1,237 -645	-34%	-$61.3K	﹤0.01%	2444
2021 Q2	$189K	Buy	1,882 +112	+6%	+$10.9K	﹤0.01%	2184
2021 Q1	$165K	Buy	1,770 +89	+5%	+$9.02K	﹤0.01%	2153
2020 Q4	$139K	Buy	1,681 +30	+2%	+$2.56K	﹤0.01%	2183
2020 Q3	$142K	Sell	1,651 -155	-9%	-$18.1K	﹤0.01%	2007
2020 Q2	$168K	Buy	+1,806	New	+$99.5K	﹤0.01%	1924

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s VBIV Position: Q3 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2022, closing a stake of 438 shares — an estimated $10.6K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VBIV in Q2 2020 and held it in 9 quarters. The position peaked at $189K in Q2 2021. 127 funds tracked by Wall St. Rank hold VBIV as of Q3 2022.

Metropolitan Life Insurance Company (MetLife) reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2022 after selling out during the quarter.
Metropolitan Life Insurance Company (MetLife) sold 438 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2022, an estimated $10.6K.
Metropolitan Life Insurance Company (MetLife) first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2020 and held it in 9 quarters.
Metropolitan Life Insurance Company (MetLife)'s VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $189K in Q2 2021.
127 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2022, filed 14 Nov 2022.